The requirement for versatility in manufacturing has actually resulted in better need from pharmaceutical firms at Fujifilm Diosynth Biotechnologies. The business has actually simply authorized a billion-dollar take care of Regeneron.
发布者:BY MARIA OUTZE NIELSEN,转转请注明出处:https://robotalks.cn/fujifilm-diosynth-biotechnologies-coo-sees-business-advantage-in-geopolitical-storm/